0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Pyridostigmine Bromide and Constipation in Parkinson's Disease

Kamal Sadjadpour, MD
JAMA. 1983;249(9):1148. doi:10.1001/jama.1983.03330330030012.
Text Size: A A A
Published online

ABSTRACT

To the Editor.—  It is well known that in Parkinson's disease, motility of the bowels is severely impaired in conjunction with reduced motility throughout. In patients who have advanced Parkinson's disease, severe constipation is often a major problem. This constipation is not sufficiently responsive to bulk laxatives, since such laxatives do not have a direct effect on intestinal motility.I have used pyridostigmine bromide for a number of years for patients who are not relieved by ordinary measures used against constipation. This drug, which is used in the treatment of myasthenia gravis, enhances intestinal motility and may in fact produce diarrhea and abdominal cramps in some patients and in large doses.I have not encountered any adverse effect on Parkinson's disease by use of this drug. No interaction with other drugs used for the treatment of Parkinson's disease or reduced effectiveness of such drugs has been observed. The dose of

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();